A physical sciences network characterization of non-tumorigenic and metastatic cells by Hielscher, Abigail et al.
Philadelphia College of Osteopathic Medicine
DigitalCommons@PCOM
PCOM Scholarly Papers
2013
A physical sciences network characterization of
non-tumorigenic and metastatic cells
Abigail Hielscher
Philadelphia College of Osteopathic Medicine, abigailhi@pcom.edu
D. Wirtz
et al.
Follow this and additional works at: http://digitalcommons.pcom.edu/scholarly_papers
Part of the Cancer Biology Commons
This Article is brought to you for free and open access by DigitalCommons@PCOM. It has been accepted for inclusion in PCOM Scholarly Papers by
an authorized administrator of DigitalCommons@PCOM. For more information, please contact library@pcom.edu.
Recommended Citation
Hielscher, Abigail; Wirtz, D.; and al., et, "A physical sciences network characterization of non-tumorigenic and metastatic cells"
(2013). PCOM Scholarly Papers. Paper 857.
http://digitalcommons.pcom.edu/scholarly_papers/857
A physical sciences network
characterization of non-tumorigenic and
metastatic cells
The Physical Sciences - Oncology Centers Network*
To investigate the transition from non-cancerous to metastatic from a physical sciences perspective, the
Physical Sciences–Oncology Centers (PS-OC) Network performed molecular and biophysical comparative
studies of the non-tumorigenic MCF-10A and metastatic MDA-MB-231 breast epithelial cell lines,
commonly used as models of cancer metastasis. Experiments were performed in 20 laboratories from 12
PS-OCs. Each laboratory was supplied with identical aliquots and common reagents and culture protocols.
Analyses of these measurements revealed dramatic differences in their mechanics, migration, adhesion,
oxygen response, and proteomic profiles. Model-based multi-omics approaches identified key differences
between these cells’ regulatory networks involved in morphology and survival. These results provide a
multifaceted description of cellular parameters of twowidely used cell lines and demonstrate the value of the
PS-OC Network approach for integration of diverse experimental observations to elucidate the phenotypes
associated with cancer metastasis.
T
he conversion from a non-tumorigenic state to ametastatic one is of critical interest in cancer cell biology, as
most deaths from cancer occur due tometastasis1. Typically, we think of the activation ofmetastasis as one of
the hallmarks of cancer2 and as a highly regulated, multistep process defined by a loss of cell adhesion due to
reduced expression of cell adhesionmolecules such as E-cadherin, degradation of the extracellular matrix (ECM),
conversion to a motile phenotype, vascular infiltration, exit and colonization to a new organ site (i.e., intra- and
extravasation), dormancy, and re-activation. From a physical sciences perspective, metastasis can be viewed as a
‘‘phase’’ transition, albeit occuring far from thermodynamic equilibrium3. Though this transition has been the
focus of much cancer biology research, there is still an incomplete understanding of this phase change, in
particular, the physical biology of the metastatic state of a cell compared to its pre-malignant state.
Understanding the physical forces that metastatic cells experience and overcome in their microenvironment
may improve our ability to target this key step in tumor progression.
The newly formed Physical Sciences-Oncology Centers (PS-OC) Network, sponsored by and under the
auspices of the Office of Physical Sciences-Oncology at the National Cancer Institute (OPSO/NCI), is a multi-
disciplinary network of twelve research centers across the US formed, in part, to test the fundamental hypothesis
that physical processes (e.g., mechanics, dynamics) play a critical role in cancer initiation andmetastasis. The PS-
OC Network brings analytic techniques and perspectives from the physical sciences to the interpretation of
biological data and consists of physicists, engineers, mathematicians, chemists, cancer biologists, and computa-
tional scientists. The goal of the PS-OC Network is to better understand the physical and chemical forces that
shape and govern the emergence and behavior of cancer at all length scales. The study described in this manu-
script focused on physical changes associated with metastasis. A controlled set of comparative studies of two cell
lines that are extensively used as cell models of cancer metastasis and straddle the metastatic transition was
undertaken by the PS-OC Network.
The cell lines analyzed were the immortalized human breast epithelial cell line MCF-10A, representing a non-
tumorigenic state, and the human metastatic breast cell line MDA-MB-231, representing a malignant state.
Distinguishing features of the adherent, non-transformed, MCF-10A cells are their lack of tumorigenicity in
nude mice, lack of anchorage-independent growth, and dependence on growth factors4. In contrast, MDA-MB-
231 cells5 form highly malignant, invasive tumors in vivo, are resistant to chemotherapy drugs such as paclitaxel,
exhibit anchorage-independent growth, and grow independently of growth factors. Although MCF-10A cells
have wild-type p53 andMDA-MB-231 cells havemutant p53, both cell lines are negative for the estrogen receptor
(ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2)6,7.
To ensure that data generated across the multiple PS-OC laboratories could be integrated, culture guidelines,
common culture reagents, and the two fully characterized, karyotyped cell lines were distributed to PS-OC
laboratories. This minimized phenotypic and genotypic drift. After demonstration of growth uniformity, the
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cells were evaluated by a battery of physical measurements, as out-
lined in Table 1, encompassing complementary physical, biochem-
ical, and molecular assays, to establish a metastatic signature across
multiple length scales, including the molecular, subcellular, cellular,
and tumor length scales. Novel biophysical techniques interrogated
classic phenotypic ‘hallmark’ properties of the two cell lines (e.g.,
morphology, motility, stress responses) and physical cell properties
(e.g., shear rheology). A novel model-based regulatory network
approach was used to generate hypotheses of linkages between
molecular and physical signatures of the cell lines. By interrogating
this one-of-a-kind dataset, this pilot study provides insight into
intrinsic differences in the physical properties of metastatic cancer
cells vs. their non-tumorigenic counterparts, while demonstrating
the importance of the technologies employed from the physical
sciences and the value of a network approach to the study of cancer
biology.
Results
In order to generate integrated data across the PS-OC Network,
the MCF-10A and MDA-MB-231 cell lines were characterized,
expanded, and distributed to each PS-OC with common protocols
and reagents to standardize culturing procedures for each cell line
(Suppl. Fig. 1a). Each PS-OC expanded the cells and was required to
submit predetermined annotations that included phase-contrast
microscopic images at specified passage numbers, seeding densities,
and culturing times to ensure phenotypic uniformity of starting
material (Suppl. Fig. 1b). Each of the laboratories then initiated
experiments using different methodologies to explore cell morpho-
logy, motility andmechanics, stress responses and survival (drug and
hypoxia), and molecular networks.
Comparative cancer cell morphology. Cancerous cells are often
described as having an altered appearance and morphology; cancer
pathologists and oncologists routinely use cell and nuclear morph-
ology to stage cancer and propose treatments. Clinical studies have
linked properties of tumor cell mass and patient survival to variations
in individual cells8 and nuclear morphology9. In particular, breast
cancer cell line morphologies have been correlated to invasiveness
and gene expression profile10. In this study, morphological
parameters of the MCF-10A and MDA-MB-231 cells, including
cell and nuclear shape, nuclear disorder strength, membrane lipid
raft abundance, and cell growth in response to matrix stiffness were
characterized. To determine the two- (2D) and three-dimensional
(3D) properties of the two cell lines, MCF-10A and MDA-MB-231
cells were grown as monolayers and imaged in 2D by differential
interference contrast microscopy (Fig. 1a). The MDA-MB-231 cells
had a higher width-to-length aspect ratio of 1:1.77 comparedwith the
smaller, rounder MCF-10A cells’ width-to-length aspect ratio of
1:1.39 (Fig. 1a). Three-dimensional cellular and nuclear shapes
were determined using single-cell optical computed tomography
and volumetric image analysis11. Representative pseudo-color
renderings of 3D cell volumes are shown in Fig. 1b. Detached
MDA-MB-231 cells exhibited consistent kidney-bean shaped
nuclei with a relatively consistent extent of concavity, whereas
nuclei of MCF-10A cells were more heterogeneous in shape.
Nuclear sphericity parameters calculated from phase-contrast
images were 1.42 and 1.39 for the MDA-MB-231 and MCF-10A
cells, respectively, demonstrating the significantly non-spherical
shapes of the nuclei of both cell types (Fig. 1b iii). This is contrary
to the popular notion of suspended cells having spherical nuclei and
is a novel observation of nuclear shape for these two otherwise well-
characterized cell lines.
Partial wave spectroscopic (PWS) microscopy is a recently intro-
duced high-resolution approach to characterize cancer cell morpho-
logy and the nanoscale architecture of the nucleus12. PWS employs
back-scattered light to quantify the spatial variations of the refractive
index or macromolecular mass density. Measurements of macromo-
lecular compaction are reported as the nuclear disorder strength, Ld,
where an increase in the disorder strength of the cell nanoarchitec-
ture is used as an indicator of early events in carcinogenesis12.
Nuclear regions of the MDA-MB-231 and MCF-10A cell lines were
analyzed and Ld calculated for each cell line and normalized toMCF-
10A values as baseline, as illustrated in Fig. 1c (PWS images are
shown on the right and the bright field reflectance (BFR) images,
from which PWS images were computed, are on the left). Metastatic
MDA-MB-231 cells exhibited a statistically significant (p, 0.0004)
80% increase in nuclear disorder strength relative to the non-tumori-
genic MCF-10A cells. This difference in nuclear Ld indicates that the
Table 1 | Cell physical parameters, methods and measurements
Cell physical parameter Technology name/ Physical method Measurement
Morphology
Cell and nuclear shape, volume 2D: Differential interference contrast microscopy 2D: Shape; length
3D: Optical computed tomography 3D: Volume; characteristic nuclear shape (nuclear
sphericity parameter)
Nuclear architecture Partial wave spectroscopy Nuclear disorder strength (Ld)
Cell growth as a function of matrix
stiffness
Immunofluorescence; confocal microscopy Cell proliferation; cell morphology
Cell surface Total internal reflection fluorescence; epifluorescence
microscopy
CD44 expression patterns; lipid raft distribution
Motility and Mechanics
Cell motility 1D, 2D, and 3D motility assays Speed; radial displacement
Cell adhesion and rolling HA Micropatterns; flow chamber adhesion assay Cell binding to HA pattern; rolling velocity
Mechanical flexibility Atomic force microscope-based nano-indentation Elastic modulus
Internal fluidity Ballistic injection nanorheology Mean square displacement
Endogenous force generation Traction force microscopy Tension maps, force magnitudes
Stress Response and Survival
Hypoxic conditions Microscopic imaging of 3D cultures (intracellular Ca21
and DNA)
2D Cell viability; 3D O2 consumption; CEA
expression
Chemical stress As above Cell viability
Abbreviations: 2D: 2-dimensional; 3D: 3-dimensional; CEA, carcinoembryonic antigen; HA, hyaluronic acid.
Footnote: Additional PS-OC methods are noted in the results and given in the supplementary information.
www.nature.com/scientificreports
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metastatic and non-tumorigenic cells have very different nuclear
architectures.
There is increasing evidence of a functional relationship between
tissue rigidity and tumor progression; indeed, tumors are often stiffer
than normal tissues13. An investigation of whether cell matrix stiff-
ness modulates cell growth andmorphology was carried out with the
two cell lines using ECM-crosslinked polyacrylamide gels of varying
stiffness (Fig. 1d). The substrate stiffness was measured by shear
rheology (the study of the flow of matter)14. When MCF-10A cells
were grown for more than 15 days on a soft matrix (with sub-
strate stiffness of either 75 Pa or 140 Pa), the cells formed well-
differentiated, hollow, growth-arrested acini. When the cell matrix
stiffness was increased to 6000 Pa, the stiffer substrate induced an
increase in cell growth but cells formed poorly differentiated mono-
layers (Fig. 1d) with nearly 70% of cells highly proliferative as
evidenced by Ki-67 positive-staining. Conversely, MDA-MB-231
cells exhibited similar morphology and growth rate regardless of
substrate, suggesting that these cells have a significantly reduced
mechano-sensitivity. This insensitivity to matrix stiffness may be
beneficial during metastasis as metastatic cells encounter different
substrates during the dissemination process, and the lack of sensitiv-
ity to matrix stiffness allows these cells to proliferate in a wide variety
of environments.
The expression and distribution of cell surface glycoproteins are a
major determinant of cellular response to the microenvironment15.
One of these glycoproteins, CD44, is a hyaluronic acid (HA) receptor
involved in cell-cell adhesion and cell-matrix interactions, which are
critical to the metastatic process. Variant isoforms have been assoc-
iated with cancer metastasis, particularly in tumors originating from
epithelia, including breast cancer16,17. Investigation of the surface
receptor expression on MCF-10A and MDA-MB-231 cells using
epifluorescence microscopy (EFM) images (Fig. 1e) revealed that
the macroscopic CD44 distributions of the two cell lines did not
differ significantly (p . 0.75) (data not shown). This confirms a
previous report using confocal microscopy, which showed a similar
localization of CD44 on MDA-MB-231 cells18. In contrast, total
internal reflection fluorescence (TIRF) images of the same cells
(Fig. 1e) indicated that CD44 was abundantly present at the point
Figure 1 | Comparative cell morphology. (a) Differential interference contrast (DIC) microscopy. (i, ii) Left: Volume rendering fromDICmicrographs
of each cell type (gray, H&E stained). Right: Same as left with EFM images of DAPI stained nuclei (blue) superposed. (iii) Aspect ratios of cell bodies
(mean 6 s.e.m.). (b) 3D cytometry. (i,ii) Pseudo-colored volume rendering of suspended and fixed H&E stained cells imaged by optical cell CT.
Cytoplasm is grey and nucleus is blue. (iii) Nuclear sphericity of the cell nuclei (mean 6 s.e.m.). (c) Nuclear disorder strength. (i, ii) Left: Bright field
reflectance (BFR) images. Right: PWS microscopic images. Color shows the magnitude of the nuclear disorder strength (Ld) (low: blue, high: red). Ld
values normalized to 1.0 for MCF-10A cells. (iii) Nuclear disorder strength (mean 6 s.e.m.). (d) Substrate stiffness. (i, ii) Confocal immunofluorescence
of cells grown for 15 days in 3D on soft (Left, 75 Pa) and hard (Right, 6000 Pa) reconstituted basement membrane-conjugated polyacrylamide gel
matrix. Cells stained for Ki-67 cell proliferation marker (red) and DNA using DAPI. (iii) Fraction of Ki-67 positive cells as function of substrate stiffness
(mean 6 s.e.m.). (e) CD44 distribution. (i, ii) CD44 distribution visualized by anti-CD44 antibodies using (Left) epifluorescence microscopy (EFM) and
(Right) total internal reflection fluorescence (TIRF). (iii) Fluorescent area in mm2 calculated from TIRF images (mean 6 s.e.m.). Bar graph compares
significant difference in immunofluorescence intensity between TIRF images for MDA and MCF cells, not the EFM images. (f) Lipid raft distribution.
(i, ii) Left: Lipid raft distribution visualized by anti-CT-B antibodies using EFM. Right: raft distribution visualized by anti-CT-B antibodies using TIRF.
(iii) Fluorescent area in mm2 calculated from TIRF images (mean 6 s.e.m.). All scale bars are 5 mm. All p-values are indicated according to the Michelin
guide scale (p # 0.001: [***]; 0.001 , p # 0.01: [**]; 0.01 , p # 0.05: [*]; 0.05 , p: ns).
www.nature.com/scientificreports
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of contact between the cell membrane and the substrate surface in the
MCF-10A but was observed at markedly lower levels (by a factor of
,4.5) in the MDA-MB-231 cells (Fig. 1e iii). Interestingly, CD44
expression and distribution were not affected in either MCF-10A
or MDA-MB-231 cells when cells were grown in 3D on substrates
of differing stiffness. CD44 was mainly present at cell-cell junctions
and was evenly distributed along the plasma membrane in both cell
types (data not shown). When the cells were treated with a fluor-
escent probe specific to membrane lipid rafts, enhanced labeling of
the MDA-MB-231 cells relative to MCF-10A cells was observed
(Fig. 1f), suggesting the presence of lipid rafts only in the metastatic
breast cancer cells. This finding is consistent with reports of elevated
levels of cholesterol-rich lipid rafts in breast and prostate cancer cells
compared to their normal counterparts17. Taken together, these
experiments suggest that although the general topography of the
two cell lines are similar, the surface presentation of the cell adhesion
protein CD44 and formation of lipid raft domains containing addi-
tional cell surface receptors are significantly different.
Comparative cancer cell motility and mechanics. Cell migration.
One of the distinguishing hallmarks of metastatic cells is their
capacity to steer through multiple physical microenvironments
such as the ECM of the stromal space and, following intravasation,
along vasculature walls. Traditionally cell motility studies have been
performed in 2D environments (i.e., flat substrates). Here, cell
motility was evaluated in one-dimensional (1D), 2D, and 3D
environments19–21. These multidimensional experiments revealed
that regulation of cell speed and maximum displacement were
critically dependent on the dimensionality of the environment. In
a 1D environment where a cell is constrained to move only forward
or backward (13 mmwide by 25 mmdeep silicon-etched fibronectin-
coated channels), MCF-10A cells traveled more than three times
faster than MDA-MB-231 cells (Fig. 2a iii). However, consistent
with their metastatic potential, MDA-MB-231 cells traveled farther
(based on radial displacement from their original position) than
MCF-10A cells along the same 1D channels (Fig. 2a iii). In a 2D
environment, MCF-10A cells moved in a circular or pin-wheel
style of motility—the leading edge swung in an arc while the
lagging edge often remained pinned in place (data not shown).
MDA-MB-231 cells moved more linearly, though more slowly, and
MCF-10A cells were found to travel farther thanMDA-MB-231 cells
on the 2D collagen matrix (Fig. 2a iii). MCF-10A cells also exhibited
slightly faster migration in a wound healing assay (see Suppl. Fig. 5).
MCF-10A cells also moved in a circular motion around the 3D void
inwhich theywere embedded, butMDA-MB-231 cells again traveled
farther than MCF-10A cells when embedded inside 3D collagen
matrices (data not shown). Thus, given the dimensional con-
straints of the cellular environment, the non-tumorigenic cells
tended to move faster than the metastatic cells, but remained
within a limited circular area, whereas MDA-MB-231 cell motility
was linear and did not exhibit the same distance limitations.
ECM matrix components are known to potentiate breast tumor
metastasis by enhancing cell invasion22, therefore, the functional
relationship between cell motility and ECM molecules such as lami-
nin (a primary ECM component of the basement membrane in
breast tissue), hyaluronic acid (HA, an anionic non-sulfated glyco-
saminoglycan spatially distributed in the ECM), and cell surface
adhesion molecule E-selectin were investigated. Traction force
microscopy (TFM) was used to measure the pulling forces exerted
by single cells on substrates with different concentrations of laminin.
MDA-MB-231 cells generated more traction forces than MCF-10A
cells at all tested laminin concentrations (0.1 mg/ml, 10 mg/ml, and
50 mg/ml) (Fig. 2b iii, intermediate concentration data not shown),
suggesting that laminin interactions may play a role in promoting
breast tumor cell aggressiveness. Cell adhesion to HA substrates and
CD44 expression in the two cell types were compared by growing
cells on micropatterned arrays with covalently linked HA (Fig. 2c).
Immunofluorescence and flow cytometry experiments confirmed
that MDA-MB-231 cells had approximately two-fold more
CD44 expression than MCF-10A cells (Fig. 2e iii). Nevertheless,
MCF-10A cells adhered preferentially to HA, whereas MDA-MB-
231 cells showed no preference (Fig. 2c iii). The lack of HA adhesion
preference of the metastatic cells is likely due to the lack of CD44 in
the membrane. This is evident in the TIRF data (Fig. 1e iii). Whereas
the EFM analysis (data not shown) shows 1:1 bulk CD44 levels, by
TIRF, levels of CD44 are 2:1, a difference presumably due to the
presence/absence of external HA in the environment.
The comparative role of E-selectin in the cell migration of meta-
static and non-malignant cells may play a critical role in the ability to
adhere to vasculature walls for efficient extravasation to secondary
organs23. For example, in trans-endothelial migration of circulating
tumor cells (CTC), endothelial cell surface ligands increase the
adhesive forces and hence the residence time and extravasation of
CTCs from the circulatory system. Fluid shear forces due to blood
flow can counteract these forces. Shear stresses from 1–4 dyn/cm2 are
typical of veins, whereas higher stresses ranging from 4–30 dyn/cm2
can occur in arteries1. Here, flow-chamber experiments showed that
MDA-MB-231 cells neither adhered nor rolled on either 5 mg/mm2
or 10 mg/mm2 E-selectin-coated surfaces over a range of physio-
logical wall shear stresses from 1–8 dyn/cm2 (data not shown). In
contrast,MCF-10A cells adhered and rolled on 5 mg/mm2 E-selectin-
coated surfaces over the entire range of stresses ranging from 1 to
8 dyn/cm2 (Fig. 2d iii). These results differ from those of Zen et al.18,
who found that MDA-MB-231 cells were able to traverse a model
endothelial monolayer in the absence of shear forces in a CD44- and
E-selectin-dependent manner17. Given the expression of CD44 on
MDA-MB-231 cells, the CD44/E-selectin binding interaction (affin-
ity and/or expression) on the cell surface may be insufficient to
increase the residence time in the presence of significant shear forces,
and other ECM ligands or adhesion molecules may compensate in
vivo. In spite of an apparent lack of HA and E-selectin binding by
MDA-MB-231 cells, both MDA-MB-231 and MCF-10A cells exhib-
ited an ECM deposition similar to that of Nuff fibroblast cells (data
not shown), however the ECM structures appear to be distinct
(Fig. 2e i).
Cell mechanics. Consistent with observations of amoeboid move-
ment of invasive cancer cells, the ability of a cell to move through
multiple tissue compartments, often via small portals, relies on
amoeba-like deformability. The mechanical deformability of MCF-
10A and MDA-MB-231 cells was measured by an atomic force
microscope (AFM) aligned with a confocal fluorescence microscope
lens (AFM-CLSM) for fluorescence lifetime imaging measurements
(FLIM) (Fig. 2f)24. Cells stained with nuclear and nucleolar dyes were
indented at distinct points over the lamella, nucleus, and nucleoli.
The resulting force-indentation curves were fitted to a modified
Hertz model in 100-nm intervals, yielding depth-dependent elastic
moduli. At shallow indentation depths, the two cell lines had similar
elastic moduli (,200 Pa). Cytoplasmic and nuclear stiffness of
MDA-MB-231 cells increased only slightly with increasing indenta-
tion depth, whereas cytoplasmic and nuclear stiffness of MCF-10A
cells both increased - though with different strain-hardening profiles
- about four-fold to an elastic modulus of,1.6 kPa. At indentation
points over nucleoli, both cell lines showed stiffening with increasing
depth, withMDA-MB-231 andMCF-10A cells rising to elastic mod-
uli of,1 kPa and,1.5 kPa, respectively, at 0.8 mm. These findings
suggest that mechanical loads are transduced through the cytoskele-
ton differently in the two cell lines. The decreased elastic modulus
and increased deformability ofMDA-MB-231 cells is consistent with
their ability to traverse narrow matrices.
Cytoplasmic viscoelasticity is also an important feature of amoeb-
oid movement. Subcellular viscoelasticity was investigated by bal-
listic injection nanorheology (BIN; movement of nanoparticles in a
www.nature.com/scientificreports
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Figure 2 | Motility and mechanics. (a) Three substrates used to monitor cell motility: 2D collagen-coated glass substrate, 3D collagen matrix, and 1D
fibronectin-coatedmicrochannels (13 mmwide, 25 mmdeep) etched in silicon.Motion tracking based on time-lapse imaging. (i) Schematic. (ii) Tracking
data. (iii) Speed (mm/min) and maximum invasion distance (mean 6 s.e.m.). (b) TFM quantified traction stresses exerted by cells on 5kPa 2D
polyacrylamide substrate mimicking mammary tumor stiffness by measuring displacement of embedded fluorescent polystyrene beads. Phase image
followed by fluorescent images of bead field under stressed and unstressed (post-trypsinization) conditions. Bead displacement yields magnitude ( |T | )
and distribution of traction stresses42. (i) Schematic. (ii) Tension maps (Left); phase images (Right); MCF-10A (Top); MDA-MB-231 (Bottom). Scale
bars: 50 mm. (iii) Force magnitudes exerted by cells at different surface laminin concentrations (mean 6 s.e.m.). (c) Microprinted Covalent HA array. (i)
Schematic. (ii) CD44 expressing MCF-10A and MDA-MB-231 cells (red) attached to FL-HA micro-patterned substrates (green) after 24h culture. Scale
bars: 50 mm. (iii) Cells attached toHA squares (mean6 s.e.m.). (d) Cells rolling on E-selectin surfaces. (i) Schematic. (ii) Phase images. Scale bars: 50 mm.
(iii) Rolling velocities and numbers of MCF-10A cells captured on surface under physiological wall shear stresses (mean 6 s.e.m.). (e) (i) SEM reveals
distinct ECM structures deposited by MCF-10A (Left; scale bar: 4 mm) compared to MDA-MB-231 (Right; Scale bar: 5 mm). (ii) IF imaging of cells
stained with fluorescein-tagged HA demonstrate expression of HA in both MCF-10A and MDA-MB-231. Scale bars: 50 mm. (iii) Flow cytometry shows
higher CD44 expression in MDA-MB-231 compared to MCF-10A (left: histogram; right: quantified MFI). (f) AFM probe aligned with confocal
fluorescence lifetime microscope scans points of interest over cytoplasm, nuclei, and nucleoli. Force-indentation curves used to calculate elastic moduli.
(i) Schematic. (ii) Curves (middle) and corresponding images (top, bottom). Scale bars: 10 mm (top); 2 mm (middle, horizontal), 0.2nN (middle,
vertical); 4 mm (bottom). (iii) Depth-dependent elastic moduli (mean 6 s.e.m.). (g) Fluorescent nanoparticles injected into cells and trajectory
monitored over time. (i) Schematic. (ii) Cell monitored in real time. Inset: nanoparticle trajectory. Scale bars: 10 mm (main); 0.2 mm (inset). (iii) MSD
values over cumulative time (mean6 s.e.m.). All p-values indicated byMichelin guide scale (p# 0.001:[***]; 0.001, p# 0.01:[**]; 0.01, p# 0.05:[*];
0.05 , p:ns).
www.nature.com/scientificreports
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viscoelastic material)25,26. Fluorescently labeled, 100 nm diameter
microspheres were ballistically injected into the cytoplasm and, after
overnight incubation, their random intracellular displacement was
followed over time (Fig. 2g). Mean squared displacement (MSD) of
the microspheres was obtained from the 20 s trajectory of each
microsphere with 30 ms temporal resolution. Consistent with the
above AFM results, the ensemble-averaged MSD of microspheres
inMDA-MB-231 cells was greater than that of MCF-10A cells, indi-
cating that the MDA-MB-231 cytoskeleton was substantially softer
than that of MCF-10A cells.
Comparative cancer cell stress response and survival. Preferential
survival under stressful conditions is a characteristic of metastatic
cancer cells; therefore, the two model cell lines were subjected to
external stresses characteristic of the tumor microenvironment,
such as hypoxia (in 2D and 3D) and low pH. Cell viability,
recovery, oxygen consumption (of single cells and populations),
and expression of the surface biomarker carcinoembryonic antigen
(CEA) were measured.
Hypoxia. Within the primary tumor, oxygen availability can vary
dramatically due to location within the tumor and its vascularity;
oxygen availability also varies temporally (e.g., due to clots). The
effects of hypoxia on cell viability, growth and recovery, and oxygen
consumption were tested in a 2D environment as well as in a patho-
logically relevant 3D culture environment. In a hypoxic (1% O2) 2D
environment, populations of both cell lines experienced relatively
small decreases in viability over a span of three days (Fig. 3a, top).
In a 3D culture environment, viability of both cell lines was appar-
ently more sensitive to hypoxia (Fig. 3a, bottom). The normalized
MCF-10A cell viability under ambient and hypoxic conditions at day
6 were 100 (6 20) % and 40 (6 10) %, respectively. The normalized
MDA-MB-231 cell viability under ambient and hypoxic conditions
at day 6 were 150 (6 30) % and 76 (6 20) %, respectively. The
apparent differences of viability in hypoxic 2D and 3D environments
require further study but may involve oxygen permeability (surface
vs. bulk effects in 3D), dead cells remaining caught in 3D scaffolding,
or changes in cell adhesion. O2 media concentrations were also mea-
sured in the 3D cultures and the normalized bulk oxygen consump-
tion rate at day 6 was determined for both cell lines (Fig. 3b, left).
Under ambient conditions, MCF-10A and MDA-MB-231 cells
exhibited similar O2 consumption rates; however, their response to
hypoxic (1%O2) treatment differed with no changes inMCF-10AO2
consumption, whereas MDA-MB-231 cells dramatically reduced O2
consumption (four-fold) when cultured in hypoxia (Fig. 3b, left). The
observed reduction of O2 consumption by MDA-MB-231 cells may
be due to an increased plasticity or adaptability related to their
tumorigenic potential. An alternative explanation may be the preex-
istence of variantMDA-MB-231 cells in the population with reduced
O2 metabolism that are positively selected for under hypoxic stress.
To examine these possibilities, oxygen consumption rates of single
cells isolated in hermetically sealed chambers were measured in nor-
moxic (17% O2) conditions (Fig. 3b, right). In these measurements,
MDA-MB-231 cells had a lower mean OCR but comparable hetero-
geneity (mean: 2.1 fmol/min, CV: 0.72) than the MCF-10A cells
(mean: 4.1 fmol/min, CV: 0.82). The histogram suggests a glycolytic
subpopulation of the metastatic cells may become dominant in hyp-
oxic conditions, but further studies are required. This hypothesis is
sketched out in Fig. 3c. In addition, measurements of the expression
of selected cell surface proteins thought to be involved in metastasis,
such as CEA (Fig. 3d), PCLP, andCD44 (Suppl. Fig. 2d), as a function
of a normal or hypoxic environment showed that MDA-MB-231
cells increased expression of CEA in response to hypoxic conditions.
Future investigations may clarify the effect of hypoxic conditions on
the expression of these proteins.
Figure 3 | Comparative cell stress responses. (a) Viability under hypoxia in
2D and 3D. Top: (2D) Cells grown in wells (triplicate) for 3 days in 1% O2.
Viability was determined every 24 h and imaged with an invertedmicroscope.
Cell viability (mean 6 s.e.m.) normalized to day 1 samples. Bottom: (3D)
DNA content per scaffold (normalized to day 1 samples) over 6 days growth
in normoxic (17% O2) and hypoxic (1% O2) conditions in 3D culture
(alginate discs). (b) Oxygen consumption rates. Left: bulk OCR (normalized
to DNA content, mean 6 s.e.m.) of cells after 6 days growth in normoxic
(17% O2) or hypoxic (1% O2) conditions in 3D culture (alginate discs);
Right: histogram of OCR of single cells measured in hermetically sealed
chambers (17% O2). (c) Schematic of a hypothetical model in which
phenotypic diversity ofMDA-MB-231 cells is relatively enhanced with respect
toMCF-10A due to enhanced population recovery after hypoxia-induced cell
death. (d) Carcinoembryonic antigen (CEA). Mean fluorescence intensity
minus isotype (MFI) of cells grown in 17% or 1% O2 (mean 6 s.e.m.).
(e) pH-induced stress. Percentages of viable cells grown in media with pH 6.8
(mean 6 s.e.m.). (f) Paclitaxel-induced stress. Percentages of viable cells after
24, 48, and 72 h incubation with various concentrations of paclitaxel (mean
6 s.e.m.). All p-values are indicated according to the Michelin guide scale
(p# 0.001: [***]; 0.001, p# 0.01: [**]; 0.01, p# 0.05: [*]; 0.05, p: ns).
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Chemical stress. Changes in the interstitial chemistry of the micro-
environment can also have a profound impact on cancer cell res-
ponse and metastasis. Low interstitial pH is typical in the tumor
microenvironment due to increased lactic acid secondary to anaero-
biosis within anoxic tumors. When cells were grown under acidic
conditions, pH 6.8 vs. neutral pH 7.4, and cell proliferation was
monitored at fixed time points (microscopic imaging of calcein-
AM and ethidium homodimer-1 staining every 24 h for 72 h),
MCF-10A viability dropped to 70% of control by 24 h and remained
there through 72 h (Fig. 3e), whereas viability of the metastatic cell
line was not significantly affected. Additionally, viability of the cell
lines was measured after 24 h, 48 h, and 72 h exposure to a range of
doses of the mitotic inhibitor paclitaxel (Fig. 3f). Although a clear
dose-dependent decrease in viability was observed in both cell lines,
the MDA-MB-231 cells were considerably less sensitive to the drug
than the MCF-10A cells.
Molecular network signatures for morphology, motility, and
stress. The goals of our studies were to broaden the set of features
that differentiate between metastatic and non-tumorigenic cells to
include physical/mechanical properties and to generate hypotheses
about how molecular-scale factors (e.g., protein and transcript level
changes) impact or are impacted by these properties. The following
molecular network analysis attempts to identify putative molecular
origins of the data from Fig. 1 and Fig. 2. Notably, in addition to the
transcriptomic data, proteomics datasets from each cell line were
collected both unperturbed and perturbed by various antagonists
that could potentially alter parameters such as stress response (e.g.
paclitaxel) andmotility andmorphology (ROCK Inhibitor Y-27632).
This allowed us to further refine our estimates of definition of genes
from the network that were putatively connected to particular
phenotypic characteristics. To connect the molecular and the
biophysical, we proceeded in three steps: 1) we identified relevant
transcriptome data (224 experimental conditions from the Gene
Expression Omnibus) for the two cell lines and generated
quantitative differential proteomics data (see Methods); 2) we
derived a computational model of cellular regulation; and 3) we
identified subsets of that model that are likely related to physical
properties of the cells.
Our transcriptional regulatory network model (Suppl. Fig. 3) con-
tains 1866 genes, 220 of which encode transcription factors (TFs) and
highlights factors that differentiate between metastatic and pre-
malignant cell types (seeMethods). In this model, each gene is repre-
sented as a ‘node’. If a gene’s abundance is regulated by another gene,
this is denotedwith an ‘edge’ between those genes. In Fig. 4a, we show
the transcription factor subset. Yellow nodes or edges indicate spe-
cificity to MCF-10A cells, whereas blue nodes or edges are more
specific to MDA-MB-231 cells. This network shows a substantial
bias towards MDA-MB-231 specific nodes and edges.
We interrogated our derived total network (Suppl. Fig. 3) to
identify sub-networks whose regulation was both highly differen-
tiated between cell types and likely connected to physical cell prop-
erties (morphology, motility, and stress). Proteomics measurements
were overlaid onto these networks.
In Figs. 4b–d, we show some of the 1-hop sub-networks (i.e., one
degree of separation between genes) selected from the millions of 1-
hop sub-networks identified. These particular networks contain one
or more interesting features: connections are specific to one cell line;
the genes are of interest to the PS-OC community and/or implicated
in cell biophysical properties; and/or the genes correspond to differ-
entiating proteomics data.
As noted above, there were numerous morphologic differences
between our cells, including factors like width-to-length ratio and
nuclear disorder factors. Notably, for the morphology sub-network
(Fig. 4b), we observe strong connections among FBN1 (encoding
fibrillin, a major extracellular microfibril in connective tissues),
ZEB1 (encoding a zinc finger transcription factor that represses T-
lymphocyte-specific IL2 gene), and TWIST1 (encoding a basic helix-
loop-helix transcription factor). The inferred network connects these
genes, whose products are known to impact the morphology of cells.
FBN1 is of particular interest because it has a large number of
MDA-MB-231-specific edges. It is a connective protein that provides
structural support for surrounding tissue. The large number of spe-
cific edges suggests that FBN1 plays a role in the deformability of the
MDA-MB-231 cells. The network analysis further infers that FBN1
has regulatory interactions with gene products involved in cellular
differentiation, adhesion, structure, and integrity, such as TGFb3
(encoding transforming growth factor b3),MMP2 (encoding matrix
metalloproteinase-2), LOX (encoding lysyl oxidase), and ACTA2
(encoding smooth muscle aortic a-actin). TGFb-3, MMP-2, and
LOX have previously been shown to be involved in tumor growth
and metastasis27,28, whereas to our knowledge ACTA2 has not.
An analysis of motility network signatures in MCF-10A and
MDA-MB-231 cells identified ITGb4 (encoding integrin b4) as a
central node (Fig. 4c). Integrin b4 is a member of the integrin family
necessary for cell-matrix and cell-cell adhesion and for motility29,30.
Our model suggests that it is a potential regulator of many gene
products involved in adhesion, migration, and invasion. This par-
ticular network also contains a large number of differentially abund-
ant gene products based on proteomics, most notably SERPINB5
(encoding serpin peptidase inhibitor, clade B, member 5), which is
upregulated in the non-malignant MCF-10A cells and is known to
act as a tumor suppressor and block the metastatic properties of
mammary tumors, further suggesting a role in differential regulation.
In the survival network, we focused initially on HIF1a (hypoxia-
inducible factor-1a), as it encodes a transcription factor known to be
involved in cell response to hypoxia31. We focused on this gene
because it is over-expressed in the metastatic cells able to survive
in areas of low O2 within a tumor (Fig. 4d). Products of genes in this
regulatory network ultimately affect the survival of a cell through
proliferation or apoptosis. Our model suggests that c-Met has reg-
ulatory relationships with both HIF1a and ITGb4 in the transcrip-
tion factor regulatory network, consistent with the reports from
Schelter et al.32 and Giancotti33 respectively. In addition, we suggest
that HIF1a regulates LOX, which has been shown to be critical for
hypoxia-induced metastasis34–36.
Discussion
This trans PS-OC laboratory network study demonstrates that cell
lines can be cultured with genotypic and phenotypic uniformity
across geographically and technologically disparate institutions to
be used in comparative studies. The results from each laboratory
can be pooled with confidence, given the known uniformity in cell
maintenance and thus the phenotypic and genotypic make-up of the
cells. This is in contrast to typical comparisons with results from
literature that are fraught with the pitfalls inherent in the use of
different experimental conditions andmaterials. In the present work,
the physical differences between a non-tumorigenic cell line (MCF-
10A) and a metastatic cell line (MDA-MB-231) that are both exten-
sively used in research were characterized. The integrated results
generate a composite and multifaceted picture (detailed in Table 2)
that is more complete than one or a few experimental approaches
would have provided. In proposing to develop a laboratory network
approach to study the physical properties of cancer cells, there was
concern about the inherent mutator genotype of the cell lines as well
as phenotypic plasticity due to variant culturing conditions, which
could result in differing cell lineages and phenotypes potentially
confounding interpretation and integration of results across the
twelve PS-OCs. Consequently, considerable work was done to ensure
that the two cell lines, culture media, and growth conditions were
standardized and that cell growth and overall morphology were
documented at regular intervals for quality control. Subsequently,
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each lab employed their own unique procedures for cell character-
ization as provided in Table 1 and the supplemental information.
Integration of the results across the study highlights the similar-
ities and differences between the cell types. For example, the apparent
phenotypic plasticity of themetastaticMDA-MB-231 cells compared
with the non-tumorigenic MCF-10A cells is illustrated at the 20 nm
scale, at which an increase in nuclear disorder strength indicative
of more variable nuclear heterochromatin structure was seen in
Figure 4 | Comparative molecular signatures for morphology, motility, and stress. (a) The largest connected subnetwork of transcription factors from
the master network (Suppl. Fig. 3) with nodes colored to provide a "summary" of the entire network. Node size shows the number of edges (connecting
lines) in the master network that were above a cutoff for specificity to either cell line. Larger nodes have more cell-line-specific edges; the largest, IKZF1,
has 67 edges above the threshold. Node color is determined by the ratio of above-cutoff edges specific to MCF-10A vs.MDA-MB-231, with yellow
denoting more MCF-10A edges and blue more MDA-MB-231 edges. Nodes with many edges specific to one cell line or the other are therefore large and
brightly colored, such as IKZF1 or COPS2. (b-d) One-hop networks from transcription factor regulators (n) to their targets (#). Each gene is
represented as a ’node’. If a gene’s abundance is regulated by another gene, this is denoted with an ’edge’ between those genes. Color of an edge indicates
the specificity of that regulatory relationship to eitherMCF-10A cells (yellow) orMDA-MB-231 cells (blue). Relationships that are equally present in both
cell types are demarked grey. Node border color indicates differential proteomics results. Yellow border nodes are upregulated in MCF-10A cells. Blue
border nodes are upregulated inMDA-MB-231 cells. Grey bordered nodes were quantified and found to be equivalent in both cell types. (b)Morphology
network. The 1-hop morphology network from FBN1 and TWIST1, LOX and LOXL1, both putatively regulated by FBN1. Both FBN1 and TWIST1 are
putatively regulated by ZEB1. Also shown are the large number of MDA-MB-231 edges from FBN1 and a fairly even distribution of edges from ZEB1.
(c) Motility network. The 1-hop network from ITGB4. ITGB4 is itself a gene of interest and is inferred to regulate EGFR and several laminins. (d) Stress
response network. The 1-hop network fromHIF1A, a transcription factor and gene of interest. It is putatively regulated byMET (upper triangle), which is
also inferred to regulate ITGB4. HIF1A putatively regulates two more genes of interest, LOX (also a putative target of FBN1 and SATB2).
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MDA-MB-231 cells, and at the mm scale, at which the cellular
deformability of the metastatic cells was found to be four-fold more
elastic than the non-tumorigenic cells as measured by AFM
(Table 2). These results are consistent with the role of the cytoskele-
ton in malignancy. The cytoskeleton functions not only as the cell
backbone but also plays an active role in cell division, differentiation
and signal transduction; modifications in the cytoskeleton have been
associated with early carcinogenesis37. In addition, the nuclear dis-
order strength is currently under evaluation as a potential early dia-
gnostic marker of metastasis38 and thus may be an indicator of early
events in carcinogenesis. Measured values for Ld have been found to
be elevated with higher neoplastic behavior in genetically altered but
microscopically indistinguishable human colon cancer cell lines12.
One benefit of this kind of trans-network study is the ability to look
at relationships between observations. For example, the AFM data
presented suggests that metastatic cells are softer. Interestingly, the
TFM data suggests that metastatic cells are able to exert increased
force. This compound observation is both phenotypically intuitive
and surprising.
One of the unanticipated findings was that motility of metastatic
MDA-MB-231 cells is profoundly different than that of MCF-10A
cells. MDA-MB-231 cells, in spite of exhibiting a slower overall
speed, traveled farther and more linearly in the more pathologically
relevant 3D motility assay than MCF-10A cells, which move in a
circular manner. Previously, motility measurements for these cells
were performed in a 2D environment; in this milieu, MCF-10A cells
traveled farther than MDA-MB-231 cells. Motility was further
explored throughmeasurements of adhesion and rolling onmatrices
with different surface ligands. The MDA-MB-231 cell surface is very
different from that of MCF-10A cells, and these differences impact
interactions with the microenvironment. CD44 distribution on the
two cell lines differs; MCF-10A cells exhibit abundant CD44 at the
cell-substrate interface, whereas the MDA-MB-231 cells had less
detectable CD44 at the cell-substrate interface. In addition, lipid rafts
were detectable on the metastatic cells but not on theMCF-10A cells.
These results suggest that although the general topography of the two
cell types is similar, the surface presentation of the cell adhesion
protein CD44 and formation of lipid raft domains containing addi-
tional cell surface receptors differ. These results are consistent with
previous findings of elevated levels of cholesterol-rich lipid rafts in
breast and prostate cancer cells compared with their normal counter-
parts13,22.
Themetastatic cells exhibited less adhesion and rolling on E-selec-
tin and HA surfaces, consistent with the lower expression of CD44
detected at the substrate/membrane contact areas in TIRF images of
the cells. The labeling experiments support the idea that the general
topographies of the two cell lines are similar. The exclusion of CD44
from the near-surface contact area in MDA-MB-231 cells or lack of
proper post-translational CD44 modification may explain their lack
of binding to the HAmicro-patterned surface. These results differed
substantially from those of Afify et al.39 who found that CD44 was
required for breast cancer cell adhesion since anti-CD44 antibodies
disrupted cell adhesion to HA-coated wells. In their study, Afify et al.
only investigated the adhesion of two breast cancer cells lines: an
MDA-MB-468 cell line that expresses high levels of CD44, and
a T47D cell line with low to negligible expression of CD44;
Table 2 | Comparative experimental physical parameters for non-tumorigenic and metastatic cells
Cell Physical Parameter Non-tumorigenic MCF-10A Metastatic MDA-MB-231
Morphology
Cell shape and volume
(2Da, 3D, and nuclear shape)b
N Smaller cell volume, spherical cell shape N Larger cell width/length ratio and volume
N Heterogeneous, non-spherical nuclear shape N Kidney bean, non-spherical nuclear shape
Nuclear architecture Baseline 80% increased nuclear disorder
Effect of matrix stiffness on cell proliferation
and morphology
Sensitive (increased proliferation with
increased stiffness)
Insensitive
Cell surface (CD44 expression patterns and
lipid raft distribution)
N Abundant CD44 at cell surface-substrate
interface
N Reduced CD44 at cell surface-substrate interface
N No measurable lipid rafts N Detectable lipid rafts
Motility
1D motility in fibronectin channel Less displacement More displacement
2D motility on collagen More displacement Less displacement
3D motility in collagen Less displacement (circular motion) More displacement (linear motion)
Traction force on laminin Less traction force More traction force
Rolling on E-selectin Yes No
Adhesion on hyaluronic acid Yes No
Mechanics
Deformability, elasticity (AFM
nanoindentation)
Less deformable, less elastic More deformable, more elastic
Internal fluidity (microparticle displacement) Less fluidity More fluidity
Stress response and survival
Hypoxia N Low cell viability, slow population recovery N Low cell viability, subpopulation survival with fast
recovery and greater proliferation
N No significant change in O2 consumption N Fourfold reduction in O2 consumption
N Low nominal CEA expression with small
increase
N Low nominal CEA expression with moderate
increase
Low pH environment Greater toxicity Sensitive
Paclitaxel Greater sensitivity Sensitive
aAbbreviations used: 1D: one-dimensional; 2D: 2-dimensionional; 3D: 3-dimensionional; CEA: carcinoembryonic antigen.
bSee text for additional explanation of experimental results.
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MDA-MB-231 cells were shown to express CD44, but at a lower level,
and their adhesion was not examined. In the Afify et al. analysis, HA
was presented singularly, whereas in our studies HA was presented
adjacent to PEG-ylated regions. Some of the present authors have
previously shown that adhesion preference to HA-presenting region
depends on the presentation of adjacent molecules40.
When subjected to stressors such as low O2 and acidosis, both
MDA-MB-231 and MCF-10A cells exhibited reduced viability as
compared with culture under ambient O2 and physiological pH;
MDA-MB-231 cell numbers were maintained to a greater degree
than MCF-10A, illustrative of the metabolic flexibility exhibited by
metastatic cells compared to the non-tumorigenic cell line. MCF-
10A cells tolerated low O2 better in 2D as compared with 3D culture,
with total cell numbers dropping by more than 50% after six days
of culture in 3D. This finding was unexpected, and may point
to different mechanisms of stress response mediated by culture
dimensionality. In hypoxic conditions, the four-fold reduction in
O2 consumption by the 3D-cultured MDA-MB-231 cells, in contrast
to the unchanged MCF-10A consumption, may be due either to
increased phenotypic plasticity or to the preexistence of an emergent
subpopulation with reduced O2 metabolism that survive under hyp-
oxic stress. These results demonstrate that it is important to monitor
not only the whole cell population but also single cells. The single cell
studies of oxygen consumption support the idea that a subset of
MDA-MB-231 cells restored the population after these microenvir-
onmental stress-caused evolutionary bottlenecksa hypothesis that is
also consistent with the results of the viability studies. Taken
together, these results confirm and extend prior observations of
the inherent capacity of metastatic cells to respond to microenviron-
ment stressors of low O2 partial pressure and acidic pH.
Proteomic network analysis of MCF-10A and MDA-MB-231 cells
confirmed changes in cell morphology and motility and identified
genes that are involved in multiple metastatic hallmark features. For
example, LOX, which is regulated in the morphology and survival
networks by FBN1 andHIF1a, respectively, is involved in extracellular
matrix remodeling and is a hypoxia-responsive gene that represses E-
cadherin, leading to cellular transformation and invasion. Through a
combination of regulatory network inferences and proteomic studies,
we interrogated the molecular origins of several classic phenotypic
‘‘hallmark’’ properties of tumor progression and metastasis.
Clearly, an important next step is to bring the biophysical assays
presented in this paper to the in vivo realm. Some of these assays
could be modified and readily extended to the in vivo case, such as
quantitative single-cell migration, traction force microscopy, and
particle tracking microrheology. Other measurements cannot be
readily conducted in vivo, such as 3D cytometry.
In sum, the results of experiments comparing parameters of cell
lines chosen to model the non-tumorigenic and metastatic states
generated internally consistent results. The metastatic cells were
more physically flexible and viable under a wider range of stresses
than the non-tumorigenic cells. In addition, cell surface protein
expression was related to the motility parameters measured. This
pilot study validates the laboratory network approach and the use
of physical sciences techniques to investigate cancer cell biology.
Methods
Cell lines. Cells were grown with standardized media and culture conditions
described by Guise et al.41 for MCF-10A cells and Debnath et al.4 for MDA-MB-231
cells. Additional specific cell growth conditions for specific assays are provided in the
supplementary information (SI Methods).
Cell morphology assays. Specific assay conditions are provided in SI Methods.
Cell motility and mechanics assays. Specific assay conditions are provided in SI
Methods.
Cell stress response and survival assays. Specific assay conditions are provided in SI
Methods.
Gene and protein expression and analysis. Specific assay conditions are provided in
SI Methods.
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